Virpax Pharmaceuticals Stock (NASDAQ: VRPX) stock price, news, charts, stock research, profile.
|Vol / Avg.115.642K / 47.991K||Mkt Cap4.283M|
|Day Range0.363 - 0.400||52 Wk Range0.325 - 1.200|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|2022-06-09||Maxim Group||Naz Rahman||Initiates Coverage On||Buy||Announces||-||4.00|
|Ticker||Company||Chg %||Mkt Cap|
You can purchase shares of Virpax Pharmaceuticals (NASDAQ: VRPX) through any online brokerage.
The latest price target for Virpax Pharmaceuticals (NASDAQ: VRPX) was reported by Maxim Group on Thursday, June 9, 2022. The analyst firm set a price target for 4.00 expecting VRPX to rise to within 12 months (a possible 994.09% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Virpax Pharmaceuticals (NASDAQ: VRPX) is $0.3656 last updated Today at December 7, 2023 at 12:47 AM UTC.
There is no dividend information for Virpax Pharmaceuticals.
Virpax Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 15, 2023.
There is no upcoming split for Virpax Pharmaceuticals.
Virpax Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.